The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies
- 1 December 2017
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 87, 21-29
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma, Inc
- Medivation, Inc
- co-developers of enzalutamide
- Astellas
- Astellas
- Medivation
- Janssen
- Astellas
- Medivation
- Astellas
- Medivation
- Janssen
- Bayer
- Astellas
This publication has 34 references indexed in Scilit:
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Journal of Clinical Oncology, 2016
- Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the scienceProstate Cancer and Prostatic Diseases, 2016
- Prognostic value of changes in quality of life scores in prostate cancerBMC Urology, 2013
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Health-related quality of life and cancer clinical trialsTherapeutic Advances in Medical Oncology, 2011
- Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trialsThe Lancet Oncology, 2009
- Quality of Life Predicts Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Versus Interferon AlfaJournal of Oncology Practice, 2009
- Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancerQuality of Life Research, 2006
- Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly StudyJournal of Clinical Oncology, 2005
- Quality of life considerations in patients with advanced lung cancerSeminars in Oncology, 2004